Effect of pioglitazone treatment on components of serum free fatty acid in type 2 diabetic patients
- VernacularTitle:吡格列酮治疗对2型糖尿病患者血清游离脂肪酸成分的影响
- Author:
Ting FENG
;
Bo YANG
;
Xiangxun ZHANG
;
Jianwei LI
;
Hongling YU
;
Haoming TIAN
- Publication Type:Journal Article
- Keywords:
Pioglitazone;
Diabetes mellitus;
type 2;
Fatty acids;
nonesterified
- From:
Chinese Journal of Endocrinology and Metabolism
2008;24(2):178-179
- CountryChina
- Language:Chinese
-
Abstract:
Components of free fatty acids (FFA) were examined by reverse high performance liquid chromatography in 25 patients with type 2 diabetes and 25 control subjects.The changes in components of FFA were observed before treatment, at 3 months and 1 year after treatment with pioglitazone in type 2 diabetic patients.The serum lauric acid, myristic acid and stearic acid levels were much higher in the diabetic patients than those in control subjects.Pioglitazone could decrease the levels of these fatty acids in the patients with type 2 diabetes mellitus.
